Replimune Group, Inc.

Home » Replimune Group, Inc.

IPO

Replimune Group, Inc.

We are a clinical-stage biotechnology company committed to applying our leading expertise in the field of oncolytic immunotherapy to transform the lives of cancer patients.

Symbol

REPL

Price Range
TBD

Anticipated Shares
TBD

Anticipated Date
TBD

Underwriters
J.P. Morgan, Leerink Partners, BMO Capital Markets

To view the prospectus for Replimune Group, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253